An unspecified number of ambulatory infusion pumps were recalled because of nearly 3,700 complaints related to several product issues, the FDA said March 20.
Supply Chain
In a Class I recall, the most serious type, customers of more than 6.6 million resuscitators were advised to discard or destroy the devices because of a manufacturing defect.
Abiomed updated warnings on more than 60,000 Impella Left Sided Heart Pumps because the device might cut the wall of the heart's left ventricle, the FDA said March 21.
"Black swan" events, or debilitating incidents that are nearly unpredictable, showcase the necessity for supply chains to have resiliency plans — but most organizations aren't prepared, according to a March 20 report from MIT Technology Review Insights.
Northwell Health is looking to simplify its supply vendor rankings by partnering with Exiger, a supply chain and third-party risk AI company.
Advertisement
The White House is expanding a data partnership with numerous U.S. companies and logistics providers to track supply chain operations in real time.
Nearly four months after the FDA said it was investigating reports of China-made syringes breaking and leaking, the agency confirmed the quality issue and found the problem is "more widespread than originally known."
Massachusetts is implementing new regulations to protect horseshoe crabs, which play a key role in drug and device safety, the Portland Press Herald reported March 19.
The American Hospital Association's supply chain group, Association for Health Care Resource & Materials Management, named Mike Schiller as its new executive director March 18.
A software company that went through Los Angeles-based Cedars-Sinai's accelerator program is aiming to streamline the medical device recall process, Fast Company reported March 14.